Website-Page-Photos-13

A BETTER WAY
TO MANAGE
PHARMACY BENEFITS


The PBM Partner Employers Deserve

Learn More About Us
Untitled-design-7


Best-in-Class Fully Bundled Solution for Employers

Specialized solution for emerging and mid-market employer groups

Innovative program package built to manage costs

Full service, in-house pharmacy benefit management


Untitled-design-6


High-Touch, High-Quality Service in Every Interaction

We treat members like family, with care and integrity.

We partner closely with our clients and advisors, working as one team with proactive and timely communication.

The best way to describe the EpiphanyRx team? Servants at heart.


Untitled-design-8-1


Transparency = Table Stakes

100% pass through of drug discounts  

100% pass through of rebates  

No conflicts of interest like spread pricing or rebate retention  


News & Insights

WHITE PAPER: ADHD Medication Trends

EpiphanyRx performed a study to identify drivers contributing to recent increased ADHD medication use within commercial employer groups. Read more about our discoveries.

WHITE PAPER: ADHD Medication Trends
WHITE PAPER: Impact of a Unique Management Strategy on GLP-1 Utilization

EpiphanyRx conducted a study to identify the impact of an electronic restricted diagnosis claim edit on GLP-1 trend in a mid-sized self-funded employer group. Learn more about our findings.

WHITE PAPER: Impact of a Unique Management Strategy on GLP-1 Utilization
The Fast Five: Still Buzzing About Biosimilars

In this Fast Five, we revisit biosimilars - still a hot industry topic. We explore biosimilar pricing and the incentives motivating drug manufacturers and pharmacy benefit managers (PBMs). We discuss formulary decisions including placement of biosimilars and removal of brand Humira®. To help us break down this complicated topic, we consulted our clinical expert, Janelle Sheen, Senior Director of Clinical Strategy.

The Fast Five: Still Buzzing About Biosimilars
The Fast Five: Transparency in the Age of GPOs

GPOs began emerging in 2019 and continue to grow. In this Fast Five, we share five insights on transparency in the age of GPOs and what to keep in mind when you are evaluating different PBMs. 

The Fast Five: Transparency in the Age of GPOs
WHITE PAPER: Impact of Preventive Medication on Pharmacy Benefit Plan Selection

EpiphanyRx studied the refill success rates for preventive medications as a measure of adherence in HDHPs across our book of business. Learn more about what we discovered.

WHITE PAPER: Impact of Preventive Medication on Pharmacy Benefit Plan Selection
The Fast Five: Let’s Be Clear. What Does Transparency Mean in PBM Pricing?

While some pharmacy benefit managers (PBMs) have been talking about transparency for years, it has become an increasingly hot topic in the health care industry. So what does transparency really mean? Let’s take a fast five (minutes) to look at PBM pricing models and how transparency comes into play.

The Fast Five: Let’s Be Clear. What Does Transparency Mean in PBM Pricing?
Your browser is out-of-date!

Update your browser to view this website correctly. Update my browser now

×